临床新兴抗肿瘤治疗方法发展概述  

Review of Development of Emerging Clinical Antitumor Therapeutics

作　　者：张文庆 吴菁 谢地 史雪聪 胡汉昆[1] ZHANG Wenqing;WU Jing;XIE Di;SHI Xuecong;HU Hankun(Department of Pharmacy,Zhongnan Hospital of Wuhan University,Wuhan 430071,China;Department of Pharmacy,Union Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430022,China;Department of Stomatology,Wuhan University Hospital,Wuhan 430071,China)

机构地区：[1]武汉大学中南医院药学部,武汉430071 [2]华中科技大学同济医学院附属协和医院药学部,武汉430022 [3]武汉大学校医院口腔科,武汉430079

出　　处：《肿瘤防治研究》2022年第3期176-181,共6页Cancer Research on Prevention and Treatment

基　　金：武汉大学2019年度医学部教学研究项目(2019059);2020年武汉大学学位与研究生教育教学改革研究项目(413200078)。

摘　　要：近年来随着肿瘤治疗方法不断进步,越来越多的新兴抗肿瘤药物获批上市,投入临床使用,此外一些处于临床试验中的治疗方法如基因疗法等也在不断取得新突破。本文主要对近年来临床上使用的新兴抗肿瘤治疗方法以及一些疗效显著、有望获批上市的抗肿瘤治疗方法作简要介绍。With the continuous progress of tumor treatment methods in recent years,more and more emerging antitumor drugs have been approved to market and put into clinical use.In addition,some treatments that are in clinical trials such as gene therapy are also continuously making new breakthroughs.In this review,we mainly give a brief introduction to the novel antineoplastic therapies that have been clinically used in recent years,as well as the ones with remarkable efficacy and are expected to be approved for marketing.

关 键 词：肿瘤 小分子靶向抗肿瘤药 免疫疗法 抗血管生成疗法 肽或蛋白质疗法 基因疗法 

分 类 号：R730.5[医药卫生—肿瘤]